endoxan
lex ano, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg - cyclophosphamide
endoxan
limedika, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg; 200 mg; 500 mg - cyclophosphamide
endoxan
limedika, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg - cyclophosphamide
endoxan baxter
limedika, uab - ciklofosfamidas - dengtos tabletės - 50 mg - cyclophosphamide
zeposia
bristol-myers squibb pharma eeig - ozanimod hidrochloridas - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresantai - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
fampridine accord
accord healthcare s.l.u. - fampridine - išsėtinė sklerozė - kiti nervų sistemos vaistai - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
fampridine teva
teva gmbh - fampridinas - pailginto atpalaidavimo tabletės - 10 mg - fampridine
spevigo
boehringer ingelheim international gmbh - spesolimab - psoriazė - imunosupresantai - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.